Nasal Spray COVID-19 Vaccine Study

Study Description:
Kaiser Research is inviting volunteers to join a research study of an investigational nasal spray vaccine against COVID-19 to help evaluate the vaccine’s safety, tolerability, and immune response. Enrollment may be ongoing for several months. Volunteers do not need to be Kaiser members.

What does participation involve?
• One dose (by nose spray into both nostrils) of the investigational study vaccine
• 8 study visits at our research clinic in downtown Seattle and 1 phone visit over a 6- to 7-month period
• Nasal swab(s) at every research clinic visit; blood draw and saliva collection at most visits
• $100 compensation for each of the first two research clinic visits (screening and enrollment) and $50 for each follow-up visit
• Answer questions on a worksheet about possible vaccine reactions every evening for at least 8 days after the study vaccine
• Free parking in our research clinic building’s garage or bus tickets provided at each visit

Participant Eligibility

Participant Eligibility:
• Healthy adults age 18-64
• Previous COVID-19 infection or vaccine must have been 16+ weeks before enrollment
• Non-smokers (including vaping)
• No intranasal steroids within 30 days of enrollment and throughout the study
• Agree to have samples stored for secondary research
• No intranasal drug use
• Hepatitis B, Hepatitis C, and HIV negative
• No significant lung conditions
• No medical conditions or medications that affect the immune system
• There are other conditions that may make you ineligible for this study

Contact

KPWHRI https://redcap.link/ib29whs7
(206) 287-2061